Skip to content
Home/Companies/Sortera Bio

Sortera Bio

·United Kingdom·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Sortera Bio?

Sortera Bio is a British company, currently owned by Cambridge Innovation Capital since 2024.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC

Key facts

HQUnited Kingdom
StatusActive

More from CIC Fund II

Other portfolio companies in the same fund.

Immutrin
Immutrin
Active
BiotechUK· 2025
TRIMTECH Therapeutics
TRIMTECH Therapeutics
Active
BiotechUK· 2025
Forefront RF
Forefront RF
Active
TelecomUK· 2024
Nuclera
Nuclera
Active
BiotechUK· 2024
Complement Therapeutics
Complement Therapeutics
Active
BiotechUK· 2023
Mosaic TX
Mosaic TX
Active
BiotechUK· 2023

Questions

Who owns Sortera Bio?

Sortera Bio is currently owned by Cambridge Innovation Capital, through CIC Fund II, since 2024.

When did Cambridge Innovation Capital acquire Sortera Bio?

Cambridge Innovation Capital acquired Sortera Bio in 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue